Cognitive Training in Parkinson's Disease
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT05495997
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Mental Imagery Training — BEHAVIORALParticipants will practice mental imagery of everyday tasks daily for 6 weeks.
- Psychoeducation — BEHAVIORALParticipants will receive psychoeducation on cognition and brain health.
Study Details
The purpose of this research study is to determine whether cognitive training will improve cognitive and brain functions in people with Parkinson's Disease (PD) during activities of daily living using cognitive evaluations and magnetic resonance imaging (MRI).
Key Dates
- Start date
- Jan 13, 2023
- Status verified
- Jul 2025
- Primary completion
- Sep 18, 2024
- Completion
- Sep 18, 2024
Study Design
- Enrollment
- 30 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Mental Imagery
- Active Comparator: Psychoeducation
Primary Outcome Measure
Change in Quality of Life in Neurological Disorders Cognitive Function Version 2 (Neuro-QoL CF v2) T-scores at 6 Weeks [ Time Frame: Baseline and 6 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale School of Medicine | New Haven | Connecticut | 06510 | - |
Find similar trials in New Haven, CT
By condition
By specialty
By research site
Related Studies
- PPMI Clinical - Establishing a Deeply Phenotyped PD CohortRecruiting · Michael J. Fox Foundation for Parkinson's Research · Birmingham, Alabama
- Intestinal Immunity in Neurologic DiseaseRecruiting · Yale University · North Haven, Connecticut
- Cognitive Effects of Exercise in Parkinson's DiseaseEnrolling By Invitation · Sule Tinaz · New Haven, Connecticut
- A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePHASE2/PHASE3 · Recruiting · Biohaven Therapeutics Ltd. · Birmingham, Alabama